Cited by 1,134Autophagy in Disease and TherapyAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities

Open access
Menzies, Fiona M., Fleming, Angeleen, Caricasole, Andrea, Bento, Carla F., Andrews, Stephen P., Ashkenazi, Avraham, Füllgrabe, Jens, Jackson, Anne +14 more·2017·Neuron

Abstract

Autophagy is a conserved pathway that delivers cytoplasmic contents to the lysosome for degradation. Here we consider its roles in neuronal health and disease. We review evidence from mouse knockout studies demonstrating the normal functions of autophagy as a protective factor against neurodegeneration associated with intracytoplasmic aggregate-prone protein accumulation as well as other roles, including in neuronal stem cell differentiation. We then describe how autophagy may be affected in a range of neurodegenerative diseases. Finally, we describe how autophagy upregulation may be a therapeutic strategy in a wide range of neurodegenerative conditions and consider possible pathways and druggable targets that may be suitable for this objective.

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2017.01.022

Cites

286 of 286 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endogenous defects in autophagy are associated with embryonic lethality, developmental defects, and multiple pathological disorders including neurodegeneration, cancer, and cardiovascular disorders.

    “and permanent or transient endogenous defects in autophagy have been associated with embryonic lethality, developmental defects, and multiple pathological disorders, including (but not limited to) neurodegeneration, cancer, and cardiovascular disorders [812–817].”
  • Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produces neurodegeneration in cell and animal model systems, supporting a role for autophagy dysfunction in age-related neurode

    “Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produce neurodegeneration in cell and animal model systems [74–81], supporting a role for autophagy dysfunction in the devel”
  • The autophagic process is essential in preserving homeostatic requirements of post-mitotic neurons in both central and peripheral nervous systems.

    “The autophagic process is essential in preserving the homeostatic requirements of post‐mitotic neurons, both at the central and at the peripheral nervous system levels (Menzies et al, 2017; Scrivo et al, 2018; Mallucci et al, 2020)”

    From Autophagy in major human diseases (2021) · cites this paper as Menzies et al, 2017

  • A comparable phenotype to ATG5 suppression has been described in Atg16l1 hypomorphic mice.

    “By analogy, a comparable phenotype has been described in Atg16l1 hypomorphic mice (Lv et al, 2014; Wu et al, 2016; Menzies et al, 2017).”

    From Autophagy in major human diseases (2021) · cites this paper as Menzies et al, 2017

  • Aβ is targeted for autophagy-dependent degradation within the lysosome, explaining why activation of autophagy reduces the burden of Aβ plaques in rodents.

    “Aβ is targeted for autophagy‐dependent degradation within the lysosome, explaining why activation of autophagy reduces the burden of Aβ plaques in rodents (Boland et al, 2008; Menzies et al, 2017; Meng et al, 2019).”

    From Autophagy in major human diseases (2021) · cites this paper as Menzies et al, 2017

Cites

Flagged first, then by citations

2 of the 288 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., Licitra, F., Lopez Ramirez, A., Pavel, M., Puri, C., Renna, M., Ricketts, T., Schlotawa, L., Vicinanza, M., Won, H., Zhu, Y., Skidmore, J., & Rubinsztein, D. C.
Affiliations
University of Cambridge (GB)
Corresponding author
Rubinsztein, David C.
Venue
Neuron
Publisher
Elsevier BV
Published
2017-03
Volume
93
Issue
5
Pages
1015-1034
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2592067246
Cited by
1,134
References
288
Citations by year
2026: 68 · 2025: 96 · 2024: 107 · 2023: 119 · 2022: 153 · 2021: 138 · 2020: 145 · 2019: 159 · 2018: 108 · 2017: 39 · 2016: 1
FWCI
16.37
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion, other-oa)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
  • Apollo
Funders
  • Tau Consortium
  • Alzheimer’s Research UK
  • Wellcome Trust (095317/Z/11/Z)
  • Cambridge Institute for Medical Research (100140/Z/12/Z)
  • NIHR Biomedical Research Unit in Dementia at Addenbrooke’s Hospital
  • The Rosetrees Trust
  • FEBS
  • Addenbrooke’s Charitable Trust
  • Sims Scholarship
  • James Baird Fund
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
autophagy, neurodegeneration, lysosomal degradation, protein aggregation, neurodegenerative diseases, therapeutic target, druggable targets, mouse knockout models
MeSH terms
Animals, Autophagy, Humans, Lysosomes, Motor Neurons, Proteins, Signal Transduction, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review